Discoveries by GNS Healthcare Causal Machine Learning and Simulation Platform, REFS, Reveal Mechanisms Driving Key Clinical Outcomes in Multiple Myeloma
Ongoing Collaboration Leveraging the Multiple Myeloma Research Foundation CoMMpass Study Reveals Drivers of High-Risk Disease and of Durable Response CAMBRIDGE, Mass. – December 6, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to massive and diverse data streams to better match drugs and other health interventions to individual […]
MS News Today Features GNS ‘Efficacy to Effectiveness’ Solution
GNS Healthcare is presenting a data-driven causal machine learning solution, called Efficacy to Effectiveness, designed to predict how potential therapies will actually perform in distinct populations. Read the complete story here.
WSJ Pro Venture Capital Coverage of Horizon Investment in GNS Highlights Application of Precision Medicine to Population Health
Health insurers that have struggled to curb rates of chronic illnesses are turning for help to innovative data-analysis startups Read the complete story here.
GNS Healthcare Announces Investment by Horizon Healthcare Services, Inc. to Expand Strategic Partnership Focused on Precision Medicine in Population Health
CAMBRIDGE, Mass. – May 23, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, today announced an investment by Horizon Healthcare Services, Inc. (New Jersey). The investment supports a strategic collaboration between the companies and […]
Health Data Management Spotlights GNS Medication Adherence Program With OmedaRx
Medication management has evolved from intuition-based treatments to population health, which emerged in the mid-1990s with a top-down, rules-based approach that treats individuals as hypotheticals, says Colin Hill, chairman and CEO of GNS Healthcare. But traditional methods to determine which patients to reach out to don’t target people who are at high risk of negative […]
MobiHealthNews: GNS Healthcare raises $10M for precision medicine analytics
Cambridge, Massachusetts-based GNS Healthcare, which has developed an analytics tool for precision medicine and population health, raised $10 million from Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund. Existing investors Cambia Health Solutions, Heritage Provider Network, and Mitsui USA, the US subsidiary of Japan’s Mitsui & Co, also participated. This brings the company’s total funding […]
GNS Healthcare Secures $10M Series C Financing to Accelerate Development of New, Data-Driven Solutions at the Intersection of Precision Medicine and Population Health
New Investors Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP Join Cambia Health Solutions, Heritage Provider Network, Mitsui CAMBRIDGE, Mass. – Dec. 8, 2015 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, […]
BioIT World: GNS Healthcare Announces $10M Financing, MMRF Study Results
GNS Healthcare announced a $10M Series C financing round today. New investors in this round—Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP—join previous investors including Cambia Health Solutions, California’s Heritage Provider Network, and Japan’s Mitsui & Co. U.S. subsidiary (“Mitsui USA”). GNS builds cloud-based big data solutions for precision medicine and […]
Personalized Medicine Coalition Welcomes GNS Healthcare as a New Member
GNS Healthcare applies causal machine learning technology to predict which treatments will work for which patients, improving individual patient outcomes and the health of populations, while reducing costs. Visit the Personalized Medicine Coalition’s Website here
GNS Healthcare Strengthens Foothold in Clinical Care Management, Appoints Nationally Regarded Authorities to Strategic Advisory Board
CAMBRIDGE, Mass. – Sept. 28, 2015 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, today announced the expansion of its Strategic Advisory Board (SAB). Joining the SAB are Susan Weaver, MD, former Chief Medical Officer of Blue Cross and Blue Shield of North Carolina; Robert […]